| ID | 466 |
|---|
| No | 466 |
|---|
| Brand Name | OLAVEX 5 MD |
|---|
| Ingredients | Olanzapine USP 5 mg |
|---|
| Dosage Form | Tablets |
|---|
| Primary Packaging | Alu-Alu Blister |
|---|
| Storage | Store below 30°C. Protect from light. |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 3 X 10'S |
|---|
| Dispensing Category | PRESCRIPTION |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | Psycholeptics |
|---|
| Indications | for the treatment of schizophrenia, for the treatment of moderate to severe
manic episode, In patients whose manic episode has responded to OLAVEX
treatment, OLAVEX is indicated for the prevention of recurrence
in patients with bipolar disorder |
|---|
| Contraindications | Hypersensitivity
Patients with known risk of narrow-angle glaucoma |
|---|
| Side Effects | Sleepiness.
Increases in the levels of prolactin in the blood.
Weight Gain
Increases in the levels of sugars in the blood and urine.
Feeling more hungry
Dizziness.
Restlessness.
Muscle stiffness or spasm (including eye movements).
Problems with speech.
Unusual movement (especially of the face or tongue).
Constipation.
Dry mouth.
Rash.
Loss of strength.
Extreme tiredness |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | Yellow colour round shape flate uncoated tablet with Breakline on one side. |
|---|
| Note | |
|---|
| License Owner | VE PRODUCTS (LAO) CO.,LTD |
|---|
| Manufacturer | WEST-COAST PHARMACEUTICAL WORKS LTD |
|---|
| Country | INDIA |
|---|
| Import Registration No | G/25/163 |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | 2024-10-15 |
|---|
| FDD Registration No | 12 I 5837/24 |
|---|
| FDD Registration Date | 2024-12-30 |
|---|
| Expiry Date | 2029-12-29 |
|---|
